Evaluation of derived coulter red blood cell parameters for the assessment of iron deficiency in adults with congenital heart disease

International Journal of Laboratory Hematology

Volumn 34, Issue 5, 2012, Pages 461-472

  Dopsaj, V ^a,b   Mikovic Golubovic, G ^a   Martinovic, J ^c   Kalimanovska Ostric, D ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b CLINICAL CENTER OF SERBIA   (Serbia)

^c Health Center Rakovica   (Serbia)

Author keywords

Ferritin; Iron depletion; Iron deficient erythropoiesis; Reticulocytes; Soluble transferrin receptor

Indexed keywords

FERRITIN; HEMOGLOBIN; TRANSFERRIN;

ADULT; ARTICLE; BLOOD CELL COUNT; CONGENITAL HEART DISEASE; CONTROLLED STUDY; DYSERYTHROPOIESIS; ERYTHROCYTE; FEMALE; HUMAN; IRON DEFICIENCY ANEMIA; IRON DEPLETION; MAJOR CLINICAL STUDY; MALE; MICROCYTIC ANEMIA; PRIORITY JOURNAL; RETICULOCYTE;

ADULT; ANEMIA, IRON-DEFICIENCY; BLOOD CELL COUNT; DISCRIMINANT ANALYSIS; ERYTHROCYTE COUNT; ERYTHROCYTE INDICES; ERYTHROCYTES; ERYTHROPOIESIS; FEMALE; FERRITINS; HAPTOGLOBINS; HEART DEFECTS, CONGENITAL; HUMANS; IRON; L-LACTATE DEHYDROGENASE; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; RETICULOCYTE COUNT; SENSITIVITY AND SPECIFICITY; TRANSFERRIN; YOUNG ADULT;

EID: 84865573170     PISSN: 17515521     EISSN: 1751553X     Source Type: Journal    
DOI: 10.1111/j.1751-553X.2012.01417.x     Document Type: Article

References (30)

1. Kalimanovska-Ostric D. (2003) Congenital heart disease in adults. In: Internal Medicine (ed. D. Manojlovic ), pp. 204-200. Serbian State Company of Textbooks, Belgrade, Serbia. (in Serbian).
2. Webb G.D., Smallhorn J.F., Therrien J. & Redington A.N. (2008) Congenital heart disease. In: A Textbook of Cardiovascular Medicine (eds D.P. Zipes, P. Libby, R.O. Bonow & E. Braunwald, Braunwald's Heart Disease), 8th edn, 1561-1625. W.B. Saunders, St. Louis, MO.
3. Broberg C.S., Bax B.E., Okonko D.O., Rampling M.W., Bayne S., Harries C., Davidson S.J., Uebing A., Khan A.A., Thein S., Gibbs J.S., Burman J. & Gatzoulis M.A. (2006) Blood viscosity and its relationship to iron deficiency symptoms and exercise capacity in adults with cyanotic congenital heart disease. Journal of the American College of Cardiology 48, 356-365.
4. DeFilippis A.P., Law K., Curtin S. & Eckman J.R. (2007) Blood is thicker than water: the management of hyperviscosity in adults with cyanotic congenital heart disease. Cardiology in Review 15, 31-34.
5. Diller G.P., Dimopoulos K., Broberg C.S., Kaya M.G., Naghotra U.S., Uebing A., Harries C., Goktekin O., Gibbs J.S. & Gatzoulis M.A. (2006) Presentation, survival prospects, and predictors of death in Eisenmenger syndrome: a combined retrospective and case-control study. European Heart Journal 27, 1737-1742.
6. Dimopoulos K., Diller G.P., Giannakoulas G., Petraco R., Chamaidi A., Karaoli E., Mullen M., Swan L., Piepoli M.F., Poole-Wilson P.A., Francis D.P. & Gatzoulis M.A. (2009) Anemia in adults with congenital heart disease relates to adverse outcome. Journal of the American College of Cardiology 54, 2093-2100.
7. Rose S.S., Shah A.A., Hoover D.R. & Saidi P. (2007) Cyanotic congenital heart disease with symptomatic erythrocytosis. Journal of General Internal Medicine 22, 1775-1777.
8. Spence M.S., Balaratnam M.S. & Gatzoulis M.A. (2007) Clinical update: cyanotic adult congenital heart disease. Lancet 370, 1530-1532.
9. Daliento L., Somerville J., Presbitero P., Menti L., Brach-Prever S., Rizzoli G. & Stone S. (1998) Eisenmenger syndrome: factors relating to deterioration and death. European Heart Journal 19, 1845-1855.
10. Kaemmerer H., Fratz S., Braun S.L., Koelling K., Eicken A., Brodherr-Heberlein S., Pietrzik K. & Hess J. (2004) Erythrocyte indexes, iron metabolism and hyperhomocysteinemia in adults with congenital heart disease. American Journal of Cardiology 94, 825-828.
11. Baynes R.D. (1994) Iron deficiency. In: Iron Metabolism in Health and Disease (eds J.H. Brock, J.W. Halliday, M.J. Pippard & L.W. Powell ), 189-225. W.B. Saunders, London.
12. Brugnara C. (2003) Iron deficiency and erythropoiesis: new diagnostic approaches. Clinical Chemistry, 49, 1573-1578.
13. Lippi G., Banfi G., Buttarello M., Ceriotti F., Daves M., Dolci A., Caputo M., Giavarina D., Montagnana M., Miconi V., Milanesi B., Mosca A., Morandini M. & Salvagno G.L. (2007) Recommendations for detection and management of unsuitable samples in clinical laboratories. Clinical Chemistry and Laboratory Medicine 45, 728-736.
14. Urrechaga E. (2009) Clinical utility of the new Beckman-Coulter parameter red blood cell size factor in the study of erythropoiesis. International Journal of Laboratory Hematology 31, 623-629.
15. Braasch E., Ludewig S. & Smettan S. (2007) Management of anemia in patients under hemodialysis and EPO therapy. Utility of new hematological parameters and serum EPO. International Journal of Laboratory Hematology 29, 46-77.
16. Urrechaga E., Ajuria I., Bereciartua E., Borque L. & Escanero J. (2010a) Microcytic Anemia Factor (Maf) In The Study of Iron Metabolism. International Journal of Laboratory Hematology 32, 94-95.
17. Cook J.D., Flowers C.H. & Skikne B.S. (2003) The quantitative assessment of body iron. Blood 101, 3359-3363.
18. Oechslin E. (2004) Hematological management of the cyanotic adults with congenital heart disease. International Journal of Cardiology 97, S109-115.
19. Thomas C. & Thomas L. (2002) Biochemical markers and hematologic indices in the diagnosis of functional iron deficiency. Clinical Chemistry, 48, 1066-1076.
20. Braun S.L., Eicken A. & Kaemmerer H. (2007) Iron deficiency in patients with extreme erythrocytosis due to cyanotic congenital heart disease. International Journal of Cardiology 116, 74-75.
21. Ryerson L.M., Wechsler B.S. & Ohye R.G. (2007) Hemolytic anemia secondary to modified Blalock-Taussig shunt. Pediatric Cardiology 28, 238-240.
22. Card T.R., Lewis R. & Weintraub R.L. (1971) Metabolic abnormalities of RBC in severe ID. Blood 37, 725-732.
23. Urrechaga E. (2010) The new mature red cell parameter, low haemoglobin density of the Beckman-Coulter LH750: clinical utility in the diagnosis of iron deficiency. International Journal of Laboratory Hematology 32, 144-150.
24. Zini G., Machin S., Briggs C., Preloznik-Zupan I., Junca J., Romero S., Beerenhout C., Garzia M., Pintado-Cros T., Junior E., Solenthaler M., Simon R., Qian Ch. & Huo Z. (2006) Multicentric evaluation of Coulter MCH and new derived Sig MCHC parameters versus CHr and %Hypo for the assessment of iron metabolism disturbances. ISLH XIXth international Symposium Amsterdam.
25. Urrechaga E., Borque L. & Escanero F.J. (2010b) Erythrocyte and reticulocyte indices on the LH 750 as potential markers of functional iron deficiency. Anemia, 2010, 1-7.
26. Dopsaj V. & Memon L. (2006) The Basis of Laboratory Diagnostics and Treatment of Anemia: Laboratory Diagnostics of Anemia. Faculty of Pharmacy University of Belgrade, Belgrade, Serbia (in Serbian)
27. Nemeth E., Valore E.V., Territo M., Schiller G., Lichtenstein A. & Ganz T. (2003) Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood, 101, 2461-2463.
28. Torti F.M. & Torti S.V. (2002) Regulation of ferritin genes and protein. Blood, 99, 3505-3516.
29. Weiss G. & Goodnough L. (2005) Anemia of chronic disease. New England Journal of Medicine, 325, 1011-1023.
30. Tay E.L., Peset A., Papaphylactou M., Inuzuka R., Alonso-Gonzalez R., Giannakoulas G., Tzifa A., Goletto S., Broberg C., Dimopoulos K. & Gatzoulis M.A. (2011) Replacement therapy for iron deficiency improves exercise capacity and quality of life in patients with cyanotic congenital heart disease and/or the Eisenmenger syndrome. International Journal of Cardiology 151, 307-312.